TrialAlimentary pharmacology & therapeutics2025

Lubiprostone Reduces Fat Content on MRI-PDFF in Patients With MASLD: A 48-Week Randomised Controlled Trial.

Mohamed El-Kassas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.